what do you eat on tirzepatide I In A Day LiveWell Endocrinology | GLP-1 medications

Some patients use the medication as a tool to reach a target weight and then transition to maintenance strategies

In October 2024, the tirzepatide shortage was resolved, which limited compounding to patient-specific needs

Mounjaro (tirzepatide) is the first dual GIP and GLP-1 receptor agonist, representing a distinct pharmacological class from exendin-4-based therapies

Understanding what is the difference between ozempic and Mounjaro helps clarify why switching requires review

The compounds mechanism is distinct from growth hormone secretagogues such as ipamorelin and GHRP-6, which act via the ghrelin receptor (GHSR-1a)

Mechanisms of plaque vulnerability and rupture